GlassScriptPhysician profile
Karam Gagi
NPI 1023754033
$3,340.14
in general payments reported to CMS, 2019-2025
33 companies · $953 in 2025
The $953 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $556 · 2023: $1,000 · 2024: $831 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,783.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $358.65 | 2023-2025 | Solitaire X, Pipeline |
| Novartis Pharmaceuticals Corporation | $353.08 | 2022-2025 | |
| Abbvie INC. | $298.09 | 2022-2025 | |
| Ucb, INC. | $279.61 | 2022-2025 | Briviact, Fintepla |
| Sk Life Science, INC. | $197.25 | 2022-2025 | |
| Microvention, INC. | $194.91 | 2024 | Stent, Tubing Kit - Stroke, Eric Retrieval Device |
| Neuropace, INC. | $151.92 | 2023 | |
| Genentech USA, INC. | $151.55 | 2024-2025 | Ocrevus, Enspryng |
| Imperative Care, INC | $128.27 | 2025 | Zoom 88-T Large Distal Platform |
| Stryker Corporation | $125.68 | 2024 | Trevo |
| Tg Therapeutics, INC. | $122.36 | 2023-2025 | |
| Eisai INC. | $100.37 | 2023-2025 | |
| Novo Nordisk INC | $94.08 | 2023 | |
| Route 92 Medical, INC. | $93.49 | 2025 | |
| Celgene Corporation | $83.78 | 2023-2025 | Zeposia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cala Health, INC. | $79.75 | 2023 | Cala Trio |
| Neurelis, INC. | $77.50 | 2022 | |
| Penumbra, INC. | $67.34 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $51.12 | 2022 | |
| Argenx US, INC. | $50.06 | 2025 | Vyvgart Hytrulo, Vyvgart |
| Takeda Pharmaceuticals U.S.A., INC. | $31.59 | 2025 | Hyqvia |
| Pyros Pharmaceuticals, INC. | $28.02 | 2024 | Vigpoder |
| Catalyst Pharmaceuticals, INC. | $26.25 | 2024 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $25.66 | 2024 | Rexulti |
| Merz Pharmaceuticals, LLC | $23.44 | 2025 | Inbrija |
| Jazz Pharmaceuticals INC. | $21.97 | 2025 | |
| Alexion Pharmaceuticals, INC. | $21.69 | 2024 | Ultomiris |
| Itf Therapeutics LLC | $19.51 | 2025 | |
| Biogen, INC. | $19.50 | 2025 | Vumerity, Tysabri |
| Boston Scientific Corporation | $19.49 | 2022 | |
| Kyowa Kirin, INC. | $16.93 | 2024 | Nourianz |
| Lilly USA, LLC | $13.81 | 2025 | Kisunla |
| Bayer Healthcare Pharmaceuticals INC. | $13.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karam Gagi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.